Internal restructuring
Sur; Región de Murcia;
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

95 jobs
Number of planned job losses
Job loss
Announcement Date
21 December 2021
Employment effect (start)
Foreseen end date


Spanish life science company Grifols has reached an agreement with the workers' representatives at its plant in Las Torres de Cotillas (Murcia), following the announcement of its collective redundancy plan worldwide, which affected at least 165 people in Murcia. The agreement reached reduces the number of people affected to 95. The agreement, endorsed by 95% of the workforce,  includes voluntary relocations to Grifols' centres in Catalonia and commitments to relocate them in future recruitments by the company in Murcia. In addition, the compensation for the 95 affected workers will be 45 days' of salary per year worked, with a maximum of 36 monthly payments, and an increase of 20% according to age ranges for those who are subject to this maximum number of monthly payments. In addition, workers dismissed will receive one payment of €6,000 for those under 50 years of age; €16,000 for those between 50 and 59 years of age; and €6,000 for those older than 60 . The agreement also guarantees an outplacement plan for staff with a commitment to relocate 70% of those affected within a maximum of nine months. The Las Torres de Cotillas plant belongs to Grifols' Hospital Division, which accounted for 2.6% of the group's revenues in 2020.



Eurofound (2021), Grifols, Internal restructuring in Spain, factsheet number 106136, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106136.